Cetuximab plus XELOX show efficacy against brain metastasis from colorectal cancer: a case report

Cetuximab plus XELOX show efficacy against brain metastasis from colorectal cancer: a case report

Brain metastasis (BM) from colorectal cancer (CRC) is rare and associated with poor prognosis. The mainstay of treatment for BM from CRC is radiotherapy, systemic treatment options for CRC can include novel targeted agents, conventional chemotherapy or a combination of both. Nevertheless, the effica...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmad KH Ibrahimi, Maysa Al-Hussaini, Dima Abu Laban, Rula Ammarin, Lina Wehbeh, Abdelatif Al-Mousa
Format: Article
Language:English
Published: Taylor & Francis Group 2023-06-01
Series:CNS Oncology
Subjects:
brain metastasis
cetuximab
colorectal cancer
targeted agents
Online Access:https://www.futuremedicine.com/doi/10.2217/cns-2023-0004
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items